|
Real-time Estimate
Cboe BZX
18:26:39 28/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 1.605 USD | +3.55% |
|
-1.23% | -19.60% |
Company Valuation: Autolus Therapeutics plc
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 378.4 | 328.8 | 1,120 | 625.4 | 529.6 | 412.6 | - | - |
| Change | - | -13.12% | 240.67% | -44.17% | -15.31% | -22.1% | - | - |
| Enterprise Value (EV) 1 | 68.11 | -53.95 | 879.8 | 89.99 | 300.3 | 260.2 | 337.4 | 353.6 |
| Change | - | -179.21% | 1,730.86% | -89.77% | 233.7% | -13.36% | 29.69% | 4.78% |
| P/E | -2.63x | -1.21x | -5.37x | -2.73x | -1.84x | -1.9x | -2.22x | -2.63x |
| PBR | 1.51x | 1.1x | 10x | 1.46x | 2.97x | - | - | - |
| PEG | - | 0.1x | 0.2x | 0.1x | -0.1x | 0.1x | 0.2x | 0.2x |
| Capitalization / Revenue | 162x | 51.7x | 660x | 61.8x | 7.03x | 2.75x | 2.14x | 1.46x |
| EV / Revenue | 29.2x | -8.48x | 518x | 8.89x | 3.98x | 1.74x | 1.75x | 1.25x |
| EV / EBITDA | -0.44x | 0.35x | -5.08x | -0.39x | -1.15x | -1.29x | -1.94x | -3.98x |
| EV / EBIT | -0.42x | 0.33x | -4.9x | -0.37x | -1.11x | -1.3x | -2.09x | -2.79x |
| EV / FCF | -0.54x | 0.44x | -5.62x | -0.39x | -0.99x | -2.15x | -3.17x | -5.45x |
| FCF Yield | -186% | 228% | -17.8% | -254% | -101% | -46.6% | -31.6% | -18.3% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.97 | -1.57 | -1.2 | -0.86 | -1.08 | -0.8149 | -0.6972 | -0.5895 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2.33 | 6.36 | 1.698 | 10.12 | 75.39 | 149.8 | 192.4 | 283.4 |
| EBITDA 1 | -154.2 | -154.3 | -173.1 | -233.7 | -260.7 | -202.3 | -173.6 | -88.94 |
| EBIT 1 | -162.7 | -161.7 | -179.7 | -241.4 | -270.5 | -199.7 | -161.8 | -126.7 |
| Net income 1 | -142.1 | -148.8 | -208.4 | -220.7 | -287.5 | -220.8 | -188.6 | -125.6 |
| Net Debt 1 | -310.3 | -382.8 | -240.3 | -535.4 | -229.3 | -152.4 | -75.11 | -58.99 |
| Reference price 2 | 5.190 | 1.900 | 6.440 | 2.350 | 1.990 | 1.550 | 1.550 | 1.550 |
| Nbr of stocks (in thousands) | 72,919 | 173,059 | 173,937 | 266,122 | 266,143 | 266,163 | - | - |
| Announcement Date | 10/03/22 | 07/03/23 | 14/03/24 | 20/03/25 | 27/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.9x | 1.71x | -1.27x | - | 413M | |
| 37.66x | 13.18x | 27.98x | 0.53% | 1,143B | |
| 39.33x | 6.61x | 18.6x | 1.99% | 647B | |
| 37.45x | 8.4x | 17.37x | 2.4% | 506B | |
| 21.46x | 5.22x | 12.98x | 2.51% | 384B | |
| 103.38x | 5.8x | 24.86x | 2.4% | 350B | |
| 21.99x | 5.69x | 13.69x | 2.94% | 293B | |
| 22.31x | 4.51x | 12.87x | 1.96% | 265B | |
| 28.42x | 7.28x | 13.03x | 2.25% | 242B | |
| -45.78x | 7.1x | 27.53x | 2.07% | 197B | |
| Average | 26.43x | 6.55x | 16.76x | 2.12% | 402.79B | |
| Weighted average by Cap. | 35.27x | 8.35x | 20.48x | 1.8% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- AUTL Stock
- Valuation Autolus Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
